Frank Morgan | Vice President, Investor Relations |
Sam Hazen | Chief Executive Officer |
Bill Rutherford | Chief Financial Officer |
Justin Lake | Wolfe Research |
A.J. Rice | Credit Suisse |
Gary Taylor | Cowen |
Ben Hendrix | RBC Capital Markets |
Whit Mayo | SVB Securities |
Pito Chickering | Deutsche Bank |
Kevin Fischbeck | Bank of America |
Ann Hynes | Mizuho Securities |
Brian Tanquilut | Jefferies |
Stephen Baxter | Wells Fargo |
Scott Fidel | Stephens |
Calvin Sternick | JPMorgan |
Lance Wilkes | Bernstein |
Jason Cassorla | Citigroup |
Steven Valiquette | Barclays |
Jamie Perse | Goldman Sachs |
Joshua Raskin | Nephron Research |
Andrew Mok | UBS |
John Ransom | Raymond James |
Good morning and welcome to the HCA Healthcare Fourth Quarter 2022 Earnings Conference Call. Today’s call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.